âš¡Sun Pharma Launches Favipiravir in India for Rs 35 Per Tablet
By ANI
Sun Pharmaceutical Industries said on Tuesday it has launched Favipiravir (200 mg) in India under the brand FluGuard at an economical price of Rs 35 per tablet for the treatment of mild to moderate cases of COVID-19.